Plasma concentration of atrial natriuretic peptide at admission and risk of cardiac death in patients with acute myocardial infarction
AUTOR(ES)
Svanegaard, Jens
RESUMO
Objective—To compare the concentration of plasma atrial natriuretic peptide in patients with acute myocardial infarction with a healthy population and to determine whether a raised concentration of plasma atrial natriuretic peptide at admission was a predictor of mortality after acute myocardial infarction.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1024967Documentos Relacionados
- Plasma atrial natriuretic peptide in patients with acute myocardial infarction: effects of streptokinase.
- Plasma atrial natriuretic peptide in patients with acute myocardial infarction: effects of streptokinase.
- Myeloperoxidase aids prognostication together with N‐terminal pro‐B‐type natriuretic peptide in high‐risk patients with acute ST elevation myocardial infarction
- Effect of β-blockers on the risk of atrial fibrillation in patients with acute myocardial infarction
- Plasma proatrial natriuretic factor (1-98) concentration after myocardial infarction: relation to indices of cardiac and renal function.